Tiburio Therapeutics Company
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2018
Employees Number:
1-10
Funding Status:
Early Stage Venture
Total Funding:
31000000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Register and Claim Ownership